compound semaglutide shortage Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders FDA says that the GLP-1

For monotherapy details, see the tirzepatide protocol page

They are real and there is science behind them

But they also reduce inflammation, improve endothelial function, shift mitochondrial metabolism, and alter the behavior of fat cells

These results suggest that the growth inhibitor of the delta cells exerts a sustained inhibitory effect on the secretion of insulin and glucagon, and that it may promote the responses of the islets to activation by cholinergic stimuli

PloS One (2013) 8:e83314

They've been a part of the health care landscape for decades, preparing custom medicines for people who need them, but booming demand for weight-loss drugs as well as resulting brand-name shortages has brought them into new prominence